HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM.

Abstract
Microangiopathy is retarded by improved blood glucose control in patients with IDDM. Whether or not this is true for macroangiopathy (atherosclerosis) has remained unclear. A total of 59 patients (44 +/- 1.5 years, previous HbA1C 9.4 +/- 0.2%, mean +/- SE) with IDDM were investigated. Of the 59 patients, 31 had been randomized to long-term intensified conventional insulin treatment (ICT), and the remaining 28 had received standard insulin treatment (ST). Blood glucose control was significantly better in the ICT patients with an HbAlc value (mean of 29 values during 10 years) of 7.1 +/- 0.1% compared with the ST patients' 8.2 +/- 0.2% (P < 0.0001). With high-frequency ultrasound, endothelial function was measured as flow-mediated dilation of the right brachial artery. The carotid arteries were scanned for plaques, intima-media thickness was measured, and arterial wall stiffness was calculated in the right common carotid artery. These measurements correlate with manifest and/or risk factors for coronary atherosclerosis. The patients in the ST group had stiffer arteries (P = 0.011) and thicker intima-media in the left common carotid artery (P = 0.009) than those in the ICT group. Patients with lower HbA1c generally had better endothelial function (P = 0.028) and less stiff arteries (P = 0.009). Better blood glucose control in patients with IDDM is related not only to less microangiopathy but also to a slower development of atherosclerosis.
AuthorsK J Jensen-Urstad, P G Reichard, J S Rosfors, L E Lindblad, M T Jensen-Urstad
JournalDiabetes (Diabetes) Vol. 45 Issue 9 Pg. 1253-8 (Sep 1996) ISSN: 0012-1797 [Print] United States
PMID8772731 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Glycated Hemoglobin A
  • Insulin
  • Nitroglycerin
Topics
  • Adult
  • Age of Onset
  • Arteriosclerosis (prevention & control)
  • Blood Glucose (physiology)
  • Blood Pressure
  • Brachial Artery (diagnostic imaging, physiopathology)
  • Carotid Arteries (drug effects, physiopathology)
  • Diabetes Mellitus, Type 1 (blood, drug therapy, physiopathology)
  • Diabetic Angiopathies (prevention & control)
  • Endothelium, Vascular (diagnostic imaging, physiopathology)
  • Female
  • Glycated Hemoglobin (analysis)
  • Humans
  • Insulin (therapeutic use)
  • Male
  • Nitroglycerin
  • Tunica Intima (drug effects, physiopathology)
  • Tunica Media (drug effects, physiopathology)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: